Eosinophil-derived neurotoxin levels at 3 months post-respiratory syncytial virus bronchiolitis are a predictive biomarker of recurrent wheezing
- PMID: 23557131
- DOI: 10.3109/1354750X.2013.773078
Eosinophil-derived neurotoxin levels at 3 months post-respiratory syncytial virus bronchiolitis are a predictive biomarker of recurrent wheezing
Abstract
Objective: To determine whether eosinophil-derived neurotoxin (EDN) is a predictive marker of recurrent wheezing episodes in post-respiratory syncytial virus (RSV) bronchiolitis.
Methods: EDN levels and recurrent wheezing episodes were serially measured in 200 infants hospitalized with RSV bronchiolitis.
Results: Serum EDN levels at 3 months correlated significantly with total wheezing episodes at 12 months in the RSV-PLC (n = 71; r = 0.720, p < 0.0001) and RSV-MONT groups (n = 79; r = 0.531, p < 0.001). Positive predictive value of 3-mo EDN level for total wheezing episodes was 57%; negative predictive value, 76%; sensitivity, 72%; specificity, 62%.
Conclusion: EDN levels have predictive value for the development of recurrent wheezing post-RSV bronchiolitis.
Similar articles
-
A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation.J Pediatr. 2010 May;156(5):749-54. doi: 10.1016/j.jpeds.2009.12.001. Epub 2010 Feb 20. J Pediatr. 2010. PMID: 20171653 Clinical Trial.
-
Soluble CD14 as a predictor of subsequent development of recurrent wheezing in hospitalized young children with respiratory syncytial virus-induced bronchiolitis.Ann Allergy Asthma Immunol. 2004 May;92(5):545-8. doi: 10.1016/S1081-1206(10)61762-0. Ann Allergy Asthma Immunol. 2004. PMID: 15191023
-
Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.Allergy. 2009 Sep;64(9):1359-65. doi: 10.1111/j.1398-9995.2009.02022.x. Epub 2009 Mar 23. Allergy. 2009. PMID: 19416146
-
Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.Pediatr Allergy Immunol. 2014 Mar;25(2):143-50. doi: 10.1111/pai.12124. Epub 2013 Oct 7. Pediatr Allergy Immunol. 2014. PMID: 24118637 Review.
-
Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis.Paediatr Respir Rev. 2000 Sep;1(3):221-7. doi: 10.1053/prrv.2000.0052. Paediatr Respir Rev. 2000. PMID: 12531083 Review.
Cited by
-
The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily.Vaccines (Basel). 2018 Nov 20;6(4):76. doi: 10.3390/vaccines6040076. Vaccines (Basel). 2018. PMID: 30463297 Free PMC article. Review.
-
Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses.Virulence. 2021 Dec;12(1):444-469. doi: 10.1080/21505594.2021.1871823. Virulence. 2021. PMID: 33660566 Free PMC article. Review.
-
Natural history of eosinophil‑derived neurotoxin levels and the onset of allergic airway disease in preschool children.Exp Ther Med. 2023 Oct 20;26(6):565. doi: 10.3892/etm.2023.12264. eCollection 2023 Dec. Exp Ther Med. 2023. PMID: 37954115 Free PMC article.
-
Selective cleavage of ncRNA and antiviral activity by RNase2/EDN in THP1-induced macrophages.Cell Mol Life Sci. 2022 Mar 26;79(4):209. doi: 10.1007/s00018-022-04229-x. Cell Mol Life Sci. 2022. PMID: 35347428 Free PMC article.
-
Eosinophil granule proteins as a biomarker in managing asthma and allergies.Asia Pac Allergy. 2023 Jun;13(2):66-71. doi: 10.5415/apallergy.0000000000000104. Epub 2023 Jun 13. Asia Pac Allergy. 2023. PMID: 37388815 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
